Advenchen Laboratories Nanjing Ltd.

1 marketed · 2 in Phase 3

Quick facts

Marketed products

Itraconazole capsule

Phase 3 pipeline

AL3818 Capsule · Oncology
AL3818 is a tyrosine kinase inhibitor that targets multiple receptor tyrosine kinases involved in tumor growth and angiogenesis.
AL8326 tablets · Oncology
AL8326 is a selective inhibitor of histone deacetylase (HDAC) that promotes acetylation of histones and non-histone proteins to alter gene expression and induce anti-tumor effects.

Phase 2 pipeline

Ticagrelor Tablets

Phase 1 pipeline

AL58805

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: